Skip to content

Comparison of intertransverse process block and paravertebral block on postoperative analgesia and recovery quality after minimally invasive esophagectomy: a non-inferiority randomized controlled trial

Comparison of intertransverse process block and paravertebral block on postoperative analgesia and recovery quality after minimally invasive esophagectomy: a non-inferiority randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104479
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Scheduled for elective minimally invasive Mckeown esophagectomy under general anesthesia; (2) Age >= 18 years; (3) American Society of Anesthesiologists (ASA) physical status classification I-III; (4) Provision of written informed consent.

Exclusion criteria

Exclusion criteria: (1) Contraindications to regional anesthesia (e.g., coagulopathy, infection at the puncture site); (2) Known allergy or contraindication to the study medications; (3) History of spinal deformity or spinal surgery; (4) History of chronic pain requiring regular opioid analgesia; (5) Inability to comprehend the study questionnaires/scales

Design outcomes

Primary

MeasureTime frame
The Overall Benefit of Analgesia Score (OBAS) at 24 h postoperatively;

Secondary

MeasureTime frame
Postoperative pain on postoperative days (POD) 1-3 and 7;Time to first analgesic request, number of patients requiring rescue analgesia and total rescue analgesic consumption;Number of demands and total drug consumption from the intravenous patient-controlled analgesia (PCA) pump;Total analgesic consumption;Quality of Recovery (QoR) scores on postoperative days (POD) 1-3 and 7;Block procedure time, dermatomal spread of the block, and block duration;Anxiety and depression scores on POD 1-3 and 7;Patient satisfaction;Time to first ambulation, first flatus, first defecation, and first oral intake;Days Alive at home in the 30 days after Surgery;Length of postoperative hospital stay;30-day all-cause mortality and readmission rates;

Countries

China

Contacts

Public ContactYu Hai

West China Hospital of Sichuan University

yuhai@scu.edu.cn+86 189 8060 1548

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026